Filing metadata

Accession number
0001127602-23-001169
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jan 09, 2023
Reporting period
Jan 03, 2023
Description
Initial ownership

Explore SEC Filings Hub